| Primary |
| Labour Induction |
18.3% |
| Postpartum Haemorrhage |
18.3% |
| Pain Management |
8.3% |
| Caesarean Section |
7.5% |
| Induced Labour |
7.5% |
| Drug Use For Unknown Indication |
6.7% |
| Product Used For Unknown Indication |
5.8% |
| Accidental Exposure |
3.3% |
| Uterine Haemorrhage |
3.3% |
| Abortion Induced |
2.5% |
| Maternal Drugs Affecting Foetus |
2.5% |
| Pain |
2.5% |
| Anti-infective Therapy |
1.7% |
| Epidural Anaesthesia |
1.7% |
| Haemorrhage |
1.7% |
| Labour Stimulation |
1.7% |
| Prophylaxis |
1.7% |
| Threatened Labour |
1.7% |
| Uterine Atony |
1.7% |
| Uterine Hypotonus |
1.7% |
|
| Drug Ineffective |
15.5% |
| Uterine Atony |
11.3% |
| Postpartum Haemorrhage |
9.9% |
| Uterine Rupture |
7.0% |
| Vascular Resistance Systemic Decreased |
5.6% |
| Wrong Drug Administered |
5.6% |
| Convulsion |
4.2% |
| Maternal Exposure During Pregnancy |
4.2% |
| Medication Error |
4.2% |
| No Therapeutic Response |
4.2% |
| Loss Of Consciousness |
2.8% |
| Neonatal Tachypnoea |
2.8% |
| Overdose |
2.8% |
| Pharmaceutical Product Complaint |
2.8% |
| Procedural Hypotension |
2.8% |
| Resuscitation |
2.8% |
| Right Atrial Pressure Increased |
2.8% |
| Therapy Non-responder |
2.8% |
| Urine Output Decreased |
2.8% |
| Uterine Contractions Abnormal |
2.8% |
|
| Secondary |
| Foetal Exposure During Pregnancy |
18.9% |
| Product Used For Unknown Indication |
18.7% |
| Prophylaxis |
9.0% |
| Anaesthesia |
8.4% |
| Labour Induction |
6.4% |
| Epidural Anaesthesia |
6.1% |
| Postpartum Haemorrhage |
5.4% |
| Depression |
3.6% |
| Pain |
3.3% |
| Caesarean Section |
2.8% |
| Analgesic Therapy |
2.6% |
| Vitamin Supplementation |
2.6% |
| Haemorrhage |
2.0% |
| Hiv Infection |
1.8% |
| Uterine Atony |
1.8% |
| Spinal Anaesthesia |
1.5% |
| Anaesthesia Procedure |
1.3% |
| Anxiety |
1.3% |
| Convulsion |
1.3% |
| Induced Labour |
1.3% |
|
| Uterine Rupture |
18.3% |
| Drug Exposure During Pregnancy |
5.6% |
| Drug Ineffective |
5.6% |
| Incorrect Route Of Drug Administration |
5.6% |
| Perineal Injury |
5.6% |
| Speech Disorder |
5.6% |
| Ventricular Hypokinesia |
5.6% |
| Ergot Poisoning |
4.2% |
| Hemiparesis |
4.2% |
| Medication Error |
4.2% |
| No Therapeutic Response |
4.2% |
| Psychomotor Retardation |
4.2% |
| Tachycardia |
4.2% |
| Uterine Atony |
4.2% |
| Uterine Inversion |
4.2% |
| Intra-uterine Death |
2.8% |
| Placenta Accreta |
2.8% |
| Postpartum Haemorrhage |
2.8% |
| Respiratory Depression |
2.8% |
| Troponin I Increased |
2.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
18.2% |
| Hiv Infection |
11.2% |
| Labour Stimulation |
8.7% |
| Prophylaxis |
7.4% |
| Spinal Anaesthesia |
7.4% |
| Drug Use For Unknown Indication |
6.1% |
| Pain |
5.1% |
| Delivery |
4.6% |
| Labour Induction |
3.6% |
| Burkitt's Lymphoma |
3.2% |
| Multiple Myeloma |
3.2% |
| Pulmonary Arterial Hypertension |
3.1% |
| Epidural Anaesthesia |
2.9% |
| Depression |
2.8% |
| Induction Of Anaesthesia |
2.5% |
| Premedication |
2.4% |
| Hypertension |
2.0% |
| Anxiety |
1.9% |
| Asthma |
1.9% |
| Maintenance Of Anaesthesia |
1.8% |
|
| Hypotension |
9.7% |
| Staphylococcal Infection |
8.9% |
| Loss Of Consciousness |
8.1% |
| Stillbirth |
7.3% |
| Vomiting |
6.5% |
| Toothache |
5.6% |
| Ventricular Septal Defect |
5.6% |
| Drug Exposure During Pregnancy |
4.8% |
| Drug Withdrawal Syndrome Neonatal |
4.8% |
| Type 2 Diabetes Mellitus |
4.8% |
| Neonatal Respiratory Distress Syndrome |
4.0% |
| Premature Baby |
4.0% |
| Uterine Atony |
4.0% |
| Myoclonus |
3.2% |
| Peripartum Cardiomyopathy |
3.2% |
| Small For Dates Baby |
3.2% |
| Urinoma |
3.2% |
| Uterine Hypotonus |
3.2% |
| Ventricular Dysfunction |
3.2% |
| Foetal Heart Rate Deceleration |
2.4% |
|
| Interacting |
| Drug Use For Unknown Indication |
28.6% |
| Anaesthesia |
14.3% |
| Intubation |
14.3% |
| Blood Pressure Management |
7.1% |
| Heart Rate Decreased |
7.1% |
| Infection Prophylaxis |
7.1% |
| Postpartum Haemorrhage |
7.1% |
| Procedural Nausea |
7.1% |
| Resuscitation |
7.1% |
|
| Drug Interaction |
50.0% |
| Dystonia |
50.0% |
|
